Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.

Ecancermedicalscience · 2015 · PMC4431402 · PMID 25987897

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

More recent data have indicated that hrHPV-DNA testing predicted residual/recurrent AIS or invasive adenocarcinoma (AdCa) during the follow-up of conservatively treated women for AIS significantly better than cytology, whose predictive power did not reach statistical significance at any of the follow-up visits.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.